Get the latest Science News and Discoveries
New SPECT/CT technique shows impressive biomarker identification, offers increased access for prostate cancer ... - EurekAlert
A novel SPECT/CT acquisition method can accurately detect radiopharmaceutical biodistribution in a convenient manner for prostate cancer patients, opening the door for more personalized treatment. Utilizing lead-212 (<sup>212</sup>Pb), the new imaging technique has the potential to change practice and increase access for patients around the world. The first-in-human images from this method were published in the April issue of <em>The </em><em>Journal of Nuclear Medicine</em>.
None
Or read this on Eureka Alert